CBD and CBG are both non-intoxicating compounds from the cannabis plant that reduce inflammation, but they work through different pathways and have some distinct effects. CBD is better known and more widely studied, while CBG is gaining attention for its antibacterial properties and potential to ease anxiety. Neither will get you high, and they share a surprising biological connection: CBG is actually the chemical parent of CBD.
How CBD and CBG Are Related
Every major cannabinoid starts as cannabigerolic acid (CBGA), the acidic form of CBG. Inside the cannabis plant, enzymes convert CBGA into the precursors of CBD, THC, and other cannabinoids. Whatever CBGA isn’t converted remains as CBG. This is why CBG is sometimes called the “mother cannabinoid.” Most cannabis strains contain very little CBG (usually under 1%) because the plant’s enzymes are efficient at turning it into other compounds. Breeders have developed CBG-rich strains by harvesting early or selecting plants with lower enzyme activity.
How They Work in the Body
CBD doesn’t bind strongly to the body’s two main cannabinoid receptors (CB1 and CB2). Instead, it works as an indirect modulator, influencing how those receptors respond to other signals. It also activates a pain-sensing channel called TRPV1, which plays a role in pain regulation and body temperature. CBD interacts with serotonin receptors as well, which helps explain its calming effects.
CBG takes a more direct approach. It acts as a partial agonist at CB2 receptors, meaning it activates them but not to their full extent. Its binding affinity for CB2 is notably stronger than for CB1, with some studies measuring a CB2 binding value around 152 nanomolar in living cells. This partial activation of CB2 receptors is thought to be a key reason CBG has strong anti-inflammatory effects. CBG also shows some measurable interaction with CB1 receptors, though the exact mechanisms there are still being worked out.
Anti-Inflammatory Effects
Both CBD and CBG consistently reduce key markers of inflammation. In studies measuring inflammatory signaling molecules, both compounds lowered levels of tumor necrosis factor alpha, interleukin-1β, interleukin-6, and interferon gamma. Across 22 studies where CBD or CBG were used, at least one inflammatory marker was reduced in every case, and 24 studies showed improvements in disease symptoms or disability.
In a colitis model that compared the two directly, CBD at 5 mg/kg reduced the inflammatory molecule IL-1β and increased the anti-inflammatory molecule IL-10 in colon tissue. CBG required a higher dose (30 mg/kg) but had broader effects: it reduced both IL-1β and interferon gamma, increased IL-10, improved intestinal permeability, and lowered markers of oxidative stress. CBG’s stronger CB2 receptor activity likely explains why researchers describe it as “potently anti-inflammatory.”
Pain Relief
CBD has shown the ability to reduce sensitivity to both mechanical pressure and heat in animal pain models when taken daily by mouth. In one experiment comparing CBD to THC, CBD reduced paw swelling from inflammation while THC did not. That said, THC appeared more effective at reducing pain-related behaviors overall, suggesting CBD’s pain benefit may come more from reducing the underlying inflammation than from blocking pain signals directly. CBG’s pain-relieving potential is less studied, but its strong anti-inflammatory profile suggests it could help with pain that stems from inflammation.
Anxiety and Mood
CBD’s calming effects are its most popular use, and CBG appears to share this benefit. In a survey of CBG users, 51% reported using it to manage anxiety, 41% for chronic pain, 33% for depression, and 31% for insomnia. A double-blind, placebo-controlled trial in healthy adults found that CBG may reduce stress and anxiety acutely. Animal research has also shown antidepressant-like effects from CBG, without the intoxicating side effects associated with THC.
CBG’s Antibacterial Strength
One area where CBG stands out is fighting bacteria. Both CBD and CBG are active against drug-resistant bacteria like MRSA, but CBG demonstrated strong inhibitory activity against all four microorganisms tested in one study, including effects on bacterial biofilms (the sticky colonies that make infections harder to treat). At concentrations that were safe for skin cells, both CBD and CBG reduced MRSA adhesion to skin cells by more than 90%. This has prompted interest in using these compounds in topical products, since they can fight harmful bacteria without disrupting the skin’s natural microbiome.
CBG and Bladder Function
CBG has a unique effect on bladder muscle. In laboratory testing on both animal and human bladder tissue, CBG reduced contractions triggered by acetylcholine, a chemical messenger that causes the bladder to squeeze. Among several cannabinoids tested, CBG and THCV were the most effective, followed by CBD. Interestingly, CBG’s effect on bladder contractions wasn’t blocked by CB1 or CB2 receptor antagonists, meaning it works through a different pathway entirely. This makes CBG a compound of interest for overactive bladder conditions.
Eye Pressure
Multiple cannabinoids, including both CBG and CBD, have been shown to lower intraocular pressure (the fluid pressure inside your eye) when applied topically or taken systemically. Elevated intraocular pressure is the primary risk factor for glaucoma, so this effect has drawn attention. However, the duration of pressure reduction from cannabinoids tends to be short, which limits practical use compared to conventional eye drops.
Side Effects and Dosing
CBD has a strong safety profile. Reviews of the evidence have found that even doses as high as 1,500 mg per day are well tolerated. When side effects occur, they’re typically mild: fatigue, diarrhea, and changes in appetite or weight. Research has analyzed CBD doses ranging from 10 to 1,500 mg daily, but there are no official dosage recommendations from the FDA. Your ideal dose depends on body weight, individual body chemistry, and the concentration of the product.
CBG has less safety data, but current research hasn’t flagged major concerns at the doses used in studies. For either compound, starting with a low dose and increasing gradually is the standard approach. One important caution applies to both: CBD and CBG can interact with medications, particularly those processed by the liver. If you take prescription drugs, checking with your pharmacist or doctor about interactions is worth the effort.
Choosing Between CBD and CBG
If you’re deciding between the two, it helps to think about what you’re trying to address. CBD has far more human research behind it and is a reasonable starting point for general inflammation, pain, or anxiety. CBG may offer advantages for gut inflammation, bladder issues, or bacterial skin concerns, based on the evidence so far. Some products combine both compounds, which aligns with the idea that cannabinoids may work better together than in isolation. CBG products tend to cost more because the compound is harder to extract in large quantities, though this gap is narrowing as CBG-rich hemp strains become more available.